Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

WHO endorses biannual injectable Lenacapavir for HIV prevention. This long-acting PrEP offers hope for high-risk groups and ...

The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...

The World Health Organization (WHO) released today new guidelines recommending the use of injectable lenacapavir (LEN) twice ...

LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...

As expected, the new recommendations that the World Health Organization (WHO) issued for HIV and sexually transmitted ...

In 2024, 89% of infants globally—about 115 million—received at least one dose of the diphtheria, tetanus, and pertussis (DTP) ...

Data released this week by the World Health Organization and UNICEF indicate modest gains in childhood vaccination rates, but ...

An estimated 14.3 million children globally remain unvaccinated and vulnerable to vaccine-preventable illnesses – meaning ...

A new global report from the World Health Organization (WHO) Commission on Social Connection reveals that one in six people ...

The facility is fully accredited by the World Health Organization (WHO) and recognized as one of the most advanced polio ...